Patent 7403550 was granted and assigned to Coherent (operating system) on July, 2008 by the United States Patent and Trademark Office.
An in vivo screening assay for identifying an agent that interferes with T cell activation and/or -differentiation and/or modulation of other inflammatory effector cells.